SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-209874
Filing Date
2023-08-11
Accepted
2023-08-11 08:31:52
Documents
15
Period of Report
2023-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d524431d8k.htm   iXBRL 8-K 29953
2 EX-99.1 d524431dex991.htm EX-99.1 95231
3 EX-99.2 d524431dex992.htm EX-99.2 9748
7 GRAPHIC g524431dsp006.jpg GRAPHIC 5210
  Complete submission text file 0001193125-23-209874.txt   282592

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA iobt-20230807.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20230807_lab.xml EX-101.LAB 17910
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20230807_pre.xml EX-101.PRE 11238
9 EXTRACTED XBRL INSTANCE DOCUMENT d524431d8k_htm.xml XML 3330
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 231161664
SIC: 2834 Pharmaceutical Preparations